Free Trial

Schroders Capital Global Innovation Trust plc - INOV (INOV) Competitors

Schroders Capital Global Innovation Trust plc - INOV logo
GBX 15.60 +0.10 (+0.65%)
As of 12:34 PM Eastern

INOV vs. PCGH, JAI, TAM, JAGI, and LWI

Should you buy Schroders Capital Global Innovation Trust plc - INOV stock or one of its competitors? MarketBeat compares Schroders Capital Global Innovation Trust plc - INOV with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Schroders Capital Global Innovation Trust plc - INOV include Polar Capital Glb Healthcare (PCGH), JP Morgan Asian Investment Trust (JAI), Tatton Asset Management (TAM), JPMorgan Asia Growth & Income (JAGI), and Lowland (LWI). These companies are all part of the "asset management" industry.

How does Schroders Capital Global Innovation Trust plc - INOV compare to Polar Capital Glb Healthcare?

Schroders Capital Global Innovation Trust plc - INOV (LON:INOV) and Polar Capital Glb Healthcare (LON:PCGH) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

Schroders Capital Global Innovation Trust plc - INOV has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Polar Capital Glb Healthcare has a beta of 0.6656899, meaning that its stock price is 33% less volatile than the broader market.

In the previous week, Schroders Capital Global Innovation Trust plc - INOV's average media sentiment score of 1.87 beat Polar Capital Glb Healthcare's score of 0.00 indicating that Schroders Capital Global Innovation Trust plc - INOV is being referred to more favorably in the media.

11.0% of Schroders Capital Global Innovation Trust plc - INOV shares are owned by institutional investors. Comparatively, 6.0% of Polar Capital Glb Healthcare shares are owned by institutional investors. 0.2% of Schroders Capital Global Innovation Trust plc - INOV shares are owned by company insiders. Comparatively, 0.2% of Polar Capital Glb Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Polar Capital Glb Healthcare has lower revenue, but higher earnings than Schroders Capital Global Innovation Trust plc - INOV. Polar Capital Glb Healthcare is trading at a lower price-to-earnings ratio than Schroders Capital Global Innovation Trust plc - INOV, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schroders Capital Global Innovation Trust plc - INOV£17.51M5.66-£38.55M£2.256.93
Polar Capital Glb Healthcare-£26.66M-14.61£77.59M-£23.13N/A

Polar Capital Glb Healthcare has a net margin of 121.51% compared to Schroders Capital Global Innovation Trust plc - INOV's net margin of 0.00%. Polar Capital Glb Healthcare's return on equity of -6.40% beat Schroders Capital Global Innovation Trust plc - INOV's return on equity.

Company Net Margins Return on Equity Return on Assets
Schroders Capital Global Innovation Trust plc - INOVN/A -19.41% -12.04%
Polar Capital Glb Healthcare 121.51%-6.40%N/A

Summary

Schroders Capital Global Innovation Trust plc - INOV and Polar Capital Glb Healthcare tied by winning 6 of the 12 factors compared between the two stocks.

How does Schroders Capital Global Innovation Trust plc - INOV compare to JP Morgan Asian Investment Trust?

Schroders Capital Global Innovation Trust plc - INOV (LON:INOV) and JP Morgan Asian Investment Trust (LON:JAI) are both small-cap asset management industry companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

JP Morgan Asian Investment Trust has higher revenue and earnings than Schroders Capital Global Innovation Trust plc - INOV. JP Morgan Asian Investment Trust is trading at a lower price-to-earnings ratio than Schroders Capital Global Innovation Trust plc - INOV, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schroders Capital Global Innovation Trust plc - INOV£17.51M5.66-£38.55M£2.256.93
JP Morgan Asian Investment Trust£25.05M0.00N/A£22.90N/A

JP Morgan Asian Investment Trust's return on equity of 0.00% beat Schroders Capital Global Innovation Trust plc - INOV's return on equity.

Company Net Margins Return on Equity Return on Assets
Schroders Capital Global Innovation Trust plc - INOVN/A -19.41% -12.04%
JP Morgan Asian Investment Trust N/A N/A N/A

11.0% of Schroders Capital Global Innovation Trust plc - INOV shares are held by institutional investors. 0.2% of Schroders Capital Global Innovation Trust plc - INOV shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Schroders Capital Global Innovation Trust plc - INOV's average media sentiment score of 1.87 beat JP Morgan Asian Investment Trust's score of 0.00 indicating that Schroders Capital Global Innovation Trust plc - INOV is being referred to more favorably in the media.

Summary

JP Morgan Asian Investment Trust beats Schroders Capital Global Innovation Trust plc - INOV on 5 of the 8 factors compared between the two stocks.

How does Schroders Capital Global Innovation Trust plc - INOV compare to Tatton Asset Management?

Schroders Capital Global Innovation Trust plc - INOV (LON:INOV) and Tatton Asset Management (LON:TAM) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

Tatton Asset Management has higher revenue and earnings than Schroders Capital Global Innovation Trust plc - INOV. Schroders Capital Global Innovation Trust plc - INOV is trading at a lower price-to-earnings ratio than Tatton Asset Management, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schroders Capital Global Innovation Trust plc - INOV£17.51M5.66-£38.55M£2.256.93
Tatton Asset Management£49.34M7.50£13.50M£27.4122.14

Tatton Asset Management has a net margin of 34.46% compared to Schroders Capital Global Innovation Trust plc - INOV's net margin of 0.00%. Tatton Asset Management's return on equity of 31.92% beat Schroders Capital Global Innovation Trust plc - INOV's return on equity.

Company Net Margins Return on Equity Return on Assets
Schroders Capital Global Innovation Trust plc - INOVN/A -19.41% -12.04%
Tatton Asset Management 34.46%31.92%16.63%

11.0% of Schroders Capital Global Innovation Trust plc - INOV shares are held by institutional investors. Comparatively, 29.8% of Tatton Asset Management shares are held by institutional investors. 0.2% of Schroders Capital Global Innovation Trust plc - INOV shares are held by insiders. Comparatively, 18.8% of Tatton Asset Management shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Tatton Asset Management has a consensus price target of GBX 797.50, suggesting a potential upside of 31.44%. Given Tatton Asset Management's stronger consensus rating and higher possible upside, analysts clearly believe Tatton Asset Management is more favorable than Schroders Capital Global Innovation Trust plc - INOV.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Schroders Capital Global Innovation Trust plc - INOV
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tatton Asset Management
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Schroders Capital Global Innovation Trust plc - INOV has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market. Comparatively, Tatton Asset Management has a beta of 0.722, suggesting that its stock price is 28% less volatile than the broader market.

In the previous week, Tatton Asset Management had 3 more articles in the media than Schroders Capital Global Innovation Trust plc - INOV. MarketBeat recorded 3 mentions for Tatton Asset Management and 0 mentions for Schroders Capital Global Innovation Trust plc - INOV. Schroders Capital Global Innovation Trust plc - INOV's average media sentiment score of 1.87 beat Tatton Asset Management's score of 0.60 indicating that Schroders Capital Global Innovation Trust plc - INOV is being referred to more favorably in the media.

Company Overall Sentiment
Schroders Capital Global Innovation Trust plc - INOV Very Positive
Tatton Asset Management Positive

Summary

Tatton Asset Management beats Schroders Capital Global Innovation Trust plc - INOV on 15 of the 16 factors compared between the two stocks.

How does Schroders Capital Global Innovation Trust plc - INOV compare to JPMorgan Asia Growth & Income?

Schroders Capital Global Innovation Trust plc - INOV (LON:INOV) and JPMorgan Asia Growth & Income (LON:JAGI) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

In the previous week, Schroders Capital Global Innovation Trust plc - INOV's average media sentiment score of 1.87 beat JPMorgan Asia Growth & Income's score of 0.00 indicating that Schroders Capital Global Innovation Trust plc - INOV is being referred to more favorably in the media.

JPMorgan Asia Growth & Income has higher revenue and earnings than Schroders Capital Global Innovation Trust plc - INOV. Schroders Capital Global Innovation Trust plc - INOV is trading at a lower price-to-earnings ratio than JPMorgan Asia Growth & Income, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schroders Capital Global Innovation Trust plc - INOV£17.51M5.66-£38.55M£2.256.93
JPMorgan Asia Growth & Income£52.04M7.63£35.93M£70.058.42

JPMorgan Asia Growth & Income has a net margin of 150.75% compared to Schroders Capital Global Innovation Trust plc - INOV's net margin of 0.00%. JPMorgan Asia Growth & Income's return on equity of 16.51% beat Schroders Capital Global Innovation Trust plc - INOV's return on equity.

Company Net Margins Return on Equity Return on Assets
Schroders Capital Global Innovation Trust plc - INOVN/A -19.41% -12.04%
JPMorgan Asia Growth & Income 150.75%16.51%-0.23%

Schroders Capital Global Innovation Trust plc - INOV has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, JPMorgan Asia Growth & Income has a beta of 0.9472936, meaning that its stock price is 5% less volatile than the broader market.

11.0% of Schroders Capital Global Innovation Trust plc - INOV shares are held by institutional investors. Comparatively, 3.9% of JPMorgan Asia Growth & Income shares are held by institutional investors. 0.2% of Schroders Capital Global Innovation Trust plc - INOV shares are held by company insiders. Comparatively, 0.3% of JPMorgan Asia Growth & Income shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

JPMorgan Asia Growth & Income beats Schroders Capital Global Innovation Trust plc - INOV on 10 of the 12 factors compared between the two stocks.

How does Schroders Capital Global Innovation Trust plc - INOV compare to Lowland?

Schroders Capital Global Innovation Trust plc - INOV (LON:INOV) and Lowland (LON:LWI) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

In the previous week, Lowland had 1 more articles in the media than Schroders Capital Global Innovation Trust plc - INOV. MarketBeat recorded 1 mentions for Lowland and 0 mentions for Schroders Capital Global Innovation Trust plc - INOV. Schroders Capital Global Innovation Trust plc - INOV's average media sentiment score of 1.87 beat Lowland's score of 1.34 indicating that Schroders Capital Global Innovation Trust plc - INOV is being referred to more favorably in the media.

Company Overall Sentiment
Schroders Capital Global Innovation Trust plc - INOV Very Positive
Lowland Positive

Lowland has higher revenue and earnings than Schroders Capital Global Innovation Trust plc - INOV. Schroders Capital Global Innovation Trust plc - INOV is trading at a lower price-to-earnings ratio than Lowland, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schroders Capital Global Innovation Trust plc - INOV£17.51M5.66-£38.55M£2.256.93
Lowland£59.47M6.25£54.35M£23.997.04

Lowland has a net margin of 291.29% compared to Schroders Capital Global Innovation Trust plc - INOV's net margin of 0.00%. Lowland's return on equity of 16.81% beat Schroders Capital Global Innovation Trust plc - INOV's return on equity.

Company Net Margins Return on Equity Return on Assets
Schroders Capital Global Innovation Trust plc - INOVN/A -19.41% -12.04%
Lowland 291.29%16.81%4.63%

Schroders Capital Global Innovation Trust plc - INOV has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Lowland has a beta of 0.875, meaning that its stock price is 13% less volatile than the broader market.

11.0% of Schroders Capital Global Innovation Trust plc - INOV shares are held by institutional investors. Comparatively, 3.9% of Lowland shares are held by institutional investors. 0.2% of Schroders Capital Global Innovation Trust plc - INOV shares are held by company insiders. Comparatively, 0.4% of Lowland shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Lowland beats Schroders Capital Global Innovation Trust plc - INOV on 11 of the 13 factors compared between the two stocks.

Get Schroders Capital Global Innovation Trust plc - INOV News Delivered to You Automatically

Sign up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INOV vs. The Competition

MetricSchroders Capital Global Innovation Trust plc - INOVAsset Management IndustryFinancial SectorLON Exchange
Market Cap£99.12M£2.37B£5.76B£2.79B
Dividend Yield0.17%5.99%5.27%6.09%
P/E Ratio6.9325.2115.77366.15
Price / Sales5.661,964.78995.1088,429.84
Price / CashN/A60.1790.3227.89
Price / Book0.741.354.407.74
Net Income-£38.55M£265.53M£1.15B£5.89B
7 Day Performance1.63%-0.13%0.43%0.82%
1 Month Performance5.41%2.39%2.28%2.78%
1 Year Performance37.44%13.44%21.88%87.90%

Schroders Capital Global Innovation Trust plc - INOV Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INOV
Schroders Capital Global Innovation Trust plc - INOV
N/AGBX 15.60
+0.6%
N/A+37.2%£99.12M£17.51M6.93N/A
PCGH
Polar Capital Glb Healthcare
N/AGBX 382.47
+2.3%
N/A+20.7%£380.04M-£26.66MN/AN/A
JAI
JP Morgan Asian Investment Trust
N/AN/AN/AN/A£377.27M£25.05M17.51N/A
TAM
Tatton Asset Management
4.0081 of 5 stars
GBX 617.38
-0.1%
GBX 797.50
+29.2%
-1.3%£376.69M£49.34M22.52103
JAGI
JPMorgan Asia Growth & Income
N/AGBX 548
+2.6%
N/A+56.8%£368.93M£52.04M7.82N/A

Related Companies and Tools


This page (LON:INOV) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners